Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi

CR Fairchild, JA Moscow, EE O'Brien and KH Cowan

Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.

The nucleotide sequence of the mdr1 gene encoding a putative drug efflux pump (P-glycoprotein) is homologous to a class of bacterial membrane-associated transport proteins. These bacterial proteins are part of a multicomponent system that includes soluble periplasmic proteins that bind substrates, channeling them through the membrane in an energy-dependent manner. We have investigated the possibility that a similar multicomponent transport system exists in a multidrug-resistant human MCF-7 breast cancer cell line that was initially selected for resistance to doxorubicin (AdrR MCF-7). AdrR MCF-7 cells overexpress both the mdr1 gene and the pi class isozyme of glutathione S- transferase (GST-pi) (EC 2.5.1.18). The latter is one of several isozymes known to have a ligand-binding function in addition to drug- metabolizing capabilities. Although we have recently shown that transfection of a functional GST-pi expression vector is insufficient to confer resistance to doxorubicin in cells that lack P-glycoprotein expression [Mol. Pharmacol. 36:22-28 (1989)], we examined the possibility that GST-pi interacts with P-glycoprotein to alter multidrug resistance. To do this, we have cloned cDNAs encoding these proteins from AdrR MCF-7 cells, constructed expression vectors containing these two genes, and transfected these vectors sequentially into drug-sensitive MCF-7 cells. The human mdr1 cDNA isolated from AdrR MCF-7 is a variant gene whose sequence differs from that isolated previously from vinblastine-resistant KB cells [Cell 53:519-529 (1989)], resulting in an amino acid substitution of alanine to serine at position 893 (mdr1/893ala). Transfection of eukaryotic expression vectors containing the mdr1 gene isolated from AdrR MCF-7 cells produced a multidrug-resistant phenotype in recipient cells, with a cross-resistance pattern similar to that in the AdrR MCF-7 cells. To determine whether GST-pi expression could augment resistance provided by mdr1, two clones transfected with mdr1, one with high levels (153% of mdr1 RNA in AdR MCF-7 cells) and one with low levels (10% of mdr1 RNA in AdrR MCF-7 cells), were subsequently cotransfected with a GST-pi expression vector and pSVNeo and selected for resistance to G418. Six of these clones contained levels of GST-pi that were 8- to 18-fold greater than GST levels found in mdr1-expressing clones transfected with nonspecific DNA. We found no difference in the degree of resistance to doxorubicin, actinomycin D, and vinblastine between the clones expressing mdr1 only and the clones expressing both mdr1 and GST- pi.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 37, Issue 6, pp. 801-809, 06/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				C.-Y. Xie, H. Zhu, L.-P. Lin, Z.-H. Miao, M.-Y. Geng, Y.-J. Cai, Y. Chen, H.-J. Zhao, H.-B. Luo, X.-W. Zhang, et al. MFTZ-1, an actinomycetes subspecies derived antitumor macrolide, functions as a novel topoisomerase II poison Mol. Cancer Ther., November 1, 2007; 6(11): 3059 - 3070. [Abstract] [Full Text] [PDF]

				K. M. Hatle, W. Neveu, O. Dienz, S. Rymarchyk, R. Barrantes, S. Hale, N. Farley, K. M. Lounsbury, J. P. Bond, D. Taatjes, et al. Methylation-Controlled J Protein Promotes c-Jun Degradation To Prevent ABCB1 Transporter Expression Mol. Cell. Biol., April 15, 2007; 27(8): 2952 - 2966. [Abstract] [Full Text] [PDF]

				M. Huang, H. Gao, Y. Chen, H. Zhu, Y. Cai, X. Zhang, Z. Miao, H. Jiang, J. Zhang, H. Shen, et al. Chimmitecan, a Novel 9-Substituted Camptothecin, with Improved Anticancer Pharmacologic Profiles In vitro and In vivo Clin. Cancer Res., February 15, 2007; 13(4): 1298 - 1307. [Abstract] [Full Text] [PDF]

				P. S. Rao, R. Govindarajan, K. B. Mallya, W. West, and U. S. Rao Characterization of a New Antibody Raised against the NH2 Terminus of P-Glycoprotein Clin. Cancer Res., August 15, 2005; 11(16): 5833 - 5839. [Abstract] [Full Text] [PDF]

				S. Zhang, X. Yang, and M. E. Morris Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport Mol. Pharmacol., May 1, 2004; 65(5): 1208 - 1216. [Abstract] [Full Text]

				X. Zhong and A. R. Safa RNA Helicase A in the MEF1 Transcription Factor Complex Up-regulates the MDR1 Gene in Multidrug-resistant Cancer Cells J. Biol. Chem., April 23, 2004; 279(17): 17134 - 17141. [Abstract] [Full Text] [PDF]

				S. Zhang and M. E. Morris Effects of the Flavonoids Biochanin A, Morin, Phloretin, and Silymarin on P-Glycoprotein-Mediated Transport J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1258 - 1267. [Abstract] [Full Text] [PDF]

				S. H. Jang, M. G. Wientjes, and J. L.-S. Au Interdependent Effect of P-Glycoprotein-Mediated Drug Efflux and Intracellular Drug Binding on Intracellular Paclitaxel Pharmacokinetics: Application of Computational Modeling J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 773 - 780. [Abstract] [Full Text] [PDF]

				C. Geroni, S. Marchini, P. Cozzi, E. Galliera, E. Ragg, T. Colombo, R. Battaglia, M. Howard, M. D'Incalci, and M. Broggini Brostallicin, a Novel Anticancer Agent Whose Activity Is Enhanced upon Binding to Glutathione Cancer Res., April 1, 2002; 62(8): 2332 - 2336. [Abstract] [Full Text] [PDF]

				M. Kim, H. Turnquist, J. Jackson, M. Sgagias, Y. Yan, M. Gong, M. Dean, J. G. Sharp, and K. Cowan The Multidrug Resistance Transporter ABCG2 (Breast Cancer Resistance Protein 1) Effluxes Hoechst 33342 and Is Overexpressed in Hematopoietic Stem Cells Clin. Cancer Res., January 1, 2002; 8(1): 22 - 28. [Abstract] [Full Text] [PDF]

				S. H. Jang, M. G. Wientjes, and J. L.-S. Au Kinetics of P-Glycoprotein-Mediated Efflux of Paclitaxel J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1236 - 1242. [Abstract] [Full Text] [PDF]

				Y.-Y. LIU, T.-Y. HAN, A. E. GIULIANO, and M. C. CABOT Ceramide glycosylation potentiates cellular multidrug resistance FASEB J, March 1, 2001; 15(3): 719 - 730. [Abstract] [Full Text] [PDF]

				J. Albertus and R. Laine Enhanced xenobiotic transporter expression in normal teleost hepatocytes: response to environmental and chemotherapeutic toxins J. Exp. Biol., January 1, 2001; 204(2): 217 - 227. [Abstract] [PDF]

				M. O'Brien, G. D. Kruh, and K. D. Tew The Influence of Coordinate Overexpression of Glutathione Phase II Detoxification Gene Products on Drug Resistance J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 480 - 487. [Abstract] [Full Text]

				H.-J. Kuh, S. H. Jang, M. G. Wientjes, and J. L.-S. Au Computational Model of Intracellular Pharmacokinetics of Paclitaxel J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 761 - 770. [Abstract] [Full Text]

				Y.-Y. Liu, T.-Y. Han, A. E. Giuliano, N. Hansen, and M. C. Cabot Uncoupling Ceramide Glycosylation by Transfection of Glucosylceramide Synthase Antisense Reverses Adriamycin Resistance J. Biol. Chem., March 15, 2000; 275(10): 7138 - 7143. [Abstract] [Full Text] [PDF]

				B. M. FREY, B. F. X. REBER, B. S. VISHWANATH, G. ESCHER, and F. J. FREY Annexin I modulates cell functions by controlling intracellular calcium release FASEB J, December 1, 1999; 13(15): 2235 - 2245. [Abstract] [Full Text]

				Y. Lavie, G. Fiucci, and M. Liscovitch Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells J. Biol. Chem., December 4, 1998; 273(49): 32380 - 32383. [Abstract] [Full Text] [PDF]

				L. A. Mickley, J.-S. Lee, Z. Weng, Z. Zhan, M. Alvarez, W. Wilson, S. E. Bates, and T. Fojo Genetic Polymorphism in MDR-1: A Tool for Examining Allelic Expression in Normal Cells, Unselected and Drug-Selected Cell Lines, and Human Tumors Blood, March 1, 1998; 91(5): 1749 - 1756. [Abstract] [Full Text] [PDF]

				G. D. Luker, T. P. Flagg, Q. Sha, K. E. Luker, C. M. Pica, C. G. Nichols, and D. Piwnica-Worms MDR1 P-glycoprotein Reduces Influx of Substrates without Affecting Membrane Potential J. Biol. Chem., December 21, 2001; 276(52): 49053 - 49060. [Abstract] [Full Text] [PDF]